UiPath (NYSE:PATH | PATH Price Prediction) has quietly become one of the more interesting orphans in enterprise software. The automation pioneer carries a market cap of just $5.3 billion, with shares down 37.8% year to date and off 84.0% over five years. Yet the underlying business is finally working: Q1 FY27 revenue of $418.38 million grew 17.3% year over year, annual recurring revenue (ARR) reached $1.901 billion, and the company posted its first GAAP profitability in company history. Free cash flow hit $352.16 million in FY26, funding $243.8 million in buybacks last quarter alone.
That combination (a depressed multiple, real cash generation, a genuine agentic AI product roadmap, and short interest sitting at 35.6% of float) creates the classic setup for strategic conversations. To be clear, no deal talks have been reported. But as a matter of strategic logic, several enterprise software giants have credible reasons to look. Below, we rank five plausible acquirers from longest shot to cleanest fit.
5. Adobe: The Longest Shot
Adobe (NASDAQ:ADBE) has the balance sheet, with an $84.3 billion market cap and AI-first ARR that tripled year over year to surpass $500 million in Q2 FY26. But Adobe’s DNA is creative and marketing workflows, not back-office RPA. CEO Shantanu Narayen just raised full-year guidance, and the Semrush deal already stretched the M&A muscle. Strategic overlap with UiPath’s financial-crime and ERP automation is thin. Fit: weak.
4. Workday: Adjacent, Not Aligned
Workday (NASDAQ:WDAY) is pushing hard into agentic AI, with more than 4,000 customers using at least one agentic product and a Recruiting Agent that supported 14 million hires. But Workday sells into HR and finance, not the horizontal automation layer UiPath occupies. A $31.6 billion market cap acquirer buying a $5.3 billion target is doable, yet returning CEO Aneel Bhusri is prioritizing internal AI builds such as Sana. Strategic rationale exists but stops short of compelling.
3. Microsoft: The Sleeping Giant
Microsoft (NASDAQ:MSFT) is already UiPath’s partner on Azure AI Foundry and Defender integrations, and its $2.8 trillion market cap makes the price rounding-error territory. Microsoft’s AI business surpassed $37 billion in annual revenue run rate, up 123%, and Copilot needs deterministic execution rails. The knock: antitrust scrutiny post-Activision, and Microsoft prefers building over buying in automation. Powerful strategic case, complicated politics.
2. Salesforce: The Agentic Consolidator
Salesforce (NYSE:CRM) has been the most aggressive AI acquirer, closing Informatica (which contributed $444 million last quarter) and pushing Agentforce ARR to $1.2 billion, up 205% year over year. UiPath’s Maestro Connector already lives on Salesforce AgentExchange. Marc Benioff called agentic AI “the biggest growth opportunity,” and Salesforce’s forward P/E of 13 gives it currency flexibility. The fit is clean, if Benioff can resist his stated aversion to large deals.
1. ServiceNow: The Cleanest Fit
ServiceNow (NYSE:NOW) is the most natural home. Bill McDermott’s platform just crossed $1 billion in AI ACV, with agentic deployments up ninefold in nine months and Q2 revenue of $3.99 billion, up 24%. ServiceNow already digested Moveworks and is pitching AI Control Tower as the market standard. Bolting on UiPath’s Maestro orchestration, WorkFusion’s financial-crime agents, and UiPath’s Fortune 500 RPA installed base would extend ServiceNow’s workflow moat directly into the automation execution layer. At $95.1 billion market cap, the deal is digestible, and the product overlap is minimal. This is the acquirer that preserves the most synergy value.
Where Private Equity Fits
A sponsor-led take-private is credible. UiPath generates real free cash flow, carries no meaningful debt, and trades at an EV/revenue of 3. The CEO’s recent divorce-settlement share transfer of 9,615,297 shares reduced the founder ownership overhang. Vista, Thoma Bravo, and Silver Lake have all done software LBOs at this profile.
What to Watch
UiPath closed at $10.20 on July 23, versus a mean analyst target of $13.25. The setup is speculative, not reported. But with agentic products moving from pilot to production, a Q2 ARR guide of $1.929 billion to $1.934 billion, and analyst consensus stuck on Hold, UiPath fits every profile of a company where strategic conversations tend to happen quietly. Investors should keep an eye on the stock through the August earnings window.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks